(19)
(11) EP 4 298 100 A1

(12)

(43) Date of publication:
03.01.2024 Bulletin 2024/01

(21) Application number: 22759019.7

(22) Date of filing: 28.02.2022
(51) International Patent Classification (IPC): 
C07D 487/04(2006.01)
(52) Cooperative Patent Classification (CPC):
F24F 5/0017; F24F 2005/0025; F24F 2221/54
(86) International application number:
PCT/HU2022/050019
(87) International publication number:
WO 2022/180416 (01.09.2022 Gazette 2022/35)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 26.02.2021 HU 2100077

(71) Applicant: Egis Gyógyszergyár Zrt.
1106 Budapest (HU)

(72) Inventors:
  • PORCS-MAKKAY, Márta
     (HU)
  • BERTHA, Ferenc
     (HU)
  • MOLNÁR, Enik
     (HU)
  • NÉMETH, Gábor
     (HU)
  • HORVÁTH, Simon
     (HU)
  • SZEBELÉDI, Ildikó
     (HU)
  • BALI, Beatrix
     (HU)
  • TELLÉR, Mónika
     (HU)
  • KÁTAINÉ FADGYAS, Katalin
     (HU)

(74) Representative: Stolmár & Partner Patentanwälte PartG mbB 
Blumenstraße 17
80331 München
80331 München (DE)

   


(54) PROCESS FOR OBTAINING AVAPRITINIB AND ITS INTERMEDIATES